XM does not provide services to residents of the United States of America.
C
C

Cigna

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health

BRIEF-The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health Aug 12 (Reuters) - Cigna Group CI.N : THE CIGNA GROUP FOUNDATION LAUNCHES GRANT PROGRAM TO IMPROVE VETERAN MENTAL HEALTH Source text for Eikon: ID:nPn2HqD7a Further company coverage: CI.N ( Reuters.Briefs@thomsonreuters.com )
C

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C

Cigna falls after unchanged annual forecast despite profit beat

BUZZ-Cigna falls after unchanged annual forecast despite profit beat ** Shares of health insurer Cigna fall 4.8% to $331.80 ** Set for biggest one-day pct. fall since Nov. 2023 ** Co maintains its annual profit forecast after Q2 profit beat ** The lack of forecast raise despite the beat will be likely viewed as a modest disappointment - Leerink Partners ** Brokerage expects investors to keenly focus on determining if this resulted from more prudent posturing or a synthetic guide-down of the seco
C

Health insurer Cigna's cautious annual forecast spooks investors, shares fall

UPDATE 2-Health insurer Cigna's cautious annual forecast spooks investors, shares fall New throughout, adds details, background, analyst comments, updates share price By Amina Niasse and Sriparna Roy Aug 1 (Reuters) - Cigna CI.N took a cautious stance on its full-year profit outlook on Thursday despite reporting lower-than-feared medical costs in the second quarter and beating Wall Street's profit estimates, and the health insurer's shares fell more than 4%.
C

Fed nods to cut, chips rebound, BoE up next

MORNING BID AMERICAS-Fed nods to cut, chips rebound, BoE up next A look at the day ahead in U.S. and global markets from Mike Dolan The Federal Reserve left Wall Street with little doubt about a first U.S. interest rate cut in seven weeks' time, but multiple cross-currents from the earnings season , Japan and China, and domestic politics all make for a noisy start to August.
A
A
A
B
C
G
I
N
R
U
X
M
J
U
U
U
F
E
W
A
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.